Loading the state's markets…
Loading the state's markets…
Loading the market…
Medicare market size, surgeons and outlook to 2030
Medicare fee-for-service cervical fusion & disc arthroplasty cases in Oklahoma: reported (2020, the pandemic year, left out of the line), then forecast with its 80% range. One year ahead, this procedure’s market forecast has been off by 6% on average (210 state-years, 2020–2024): a close guide.
| Year | Surgeons | Medicare FFS | Advantage share |
|---|---|---|---|
| 2019 | 41 | 1,252 | 24% |
| 2020 | 31 | 1,035 | 28% |
| 2021 | 27 | 1,012 | 34% |
| 2022 | 29 | 973 | 38% |
| 2023 | 28 | 854 | 42% |
| 2024 | 28 | 913 | 44% |
| 2025 from claims | – | 972 786–1,141 | 46% |
| 2026 forecast | – | 973 762–1,222 | 46% |
| 2027 forecast | – | 975 723–1,290 | 47% |
| 2028 forecast | – | 978 692–1,350 | 48% |
| 2029 forecast | – | 980 666–1,405 | 49% |
| 2030 forecast | – | 982 643–1,457 | 49% |
ACDF, posterior cervical fusion, cervical total disc replacement. Professional codes (what the surgeon bills): CPT 22551, 22600, 22856; the hospital bills MS-DRG 471, 472, 473, 429, 430.
Surgeons and fee-for-service cases are from CMS’s Medicare Physician & Other Practitioners files, counted where the surgeon billed; state totals include the cases CMS leaves out of the surgeon-level file (under 11 patients). All Medicare adds patients in Medicare Advantage at the state’s enrollment share; all payers scales Medicare by its share of the procedure nationally. The forecast carries cases per resident 65+ forward with the Census projection of residents 65+. How the numbers are made · Data sources
The 10 busiest do 48% of the cases CMS names in Oklahoma; 20 surgeons do 80% of them.
MedaRep names every one, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
In 2025, 58% inpatient hospital, 42% hospital outpatient.
CMS rule changes ahead
From CMS’s OPPS/ASC final rules; the move measured on CMS’s claim summary, nationally, code by code. Medicare only, and not in the projected bars.
| State | Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast |
|---|---|---|---|---|---|---|
| Texas | 91 | 4,236−3.4%/yr | −3.4%/yr | 1.9 | 3% | 4,580 in 2030+1.3%/yr |
| Florida | 85 | 3,684−1%/yr | −1%/yr | 1.6 | 7% | 4,300 in 2030+2.6%/yr |
| North Carolina | 26 | 1,686−6.3%/yr | −6.3%/yr | 1.6 | 6% | 1,550 in 2030−1.4%/yr |
| Georgia | 34 | 1,567−5.6%/yr | −5.6%/yr | 1.7 | 7% | 1,710 in 2030+1.4%/yr |
| Virginia | 35 | 1,533−3.6%/yr | −3.6%/yr | 1.4 | 1% | 1,680 in 2030+1.6%/yr |
| Maryland | 34 | 1,470−1.4%/yr | −1.4%/yr | 1.6 | 5% | 1,510 in 2030+0.4%/yr |
| Tennessee | 32 | 1,388−3%/yr | −3%/yr | 1.9 | 6% | 1,430 in 2030+0.5%/yr |
| South Carolina | 31 | 1,151−3.6%/yr | −3.6%/yr | 1.6 | 4% | 1,220 in 2030+0.9%/yr |
| Louisiana | 21 | 996−3.3%/yr | −3.3%/yr | 2.3 | 2% | 1,040 in 2030+0.8%/yr |
| Alabama | 31 | 919−9.6%/yr | −9.6%/yr | 2.0 | 4% | 880 in 2030−0.7%/yr |
| Kentucky | 10 | 605−9.7%/yr | −9.7%/yr | 1.3 | 2% | 730 in 2030+3.1%/yr |
| Arkansas | 15 | 594−6.2%/yr | −6.2%/yr | 1.5 | 5% | 650 in 2030+1.4%/yr |
| Mississippi | 13 | 506−7.3%/yr | −7.3%/yr | 1.3 | 24% | 500 in 2030−0.3%/yr |
| Delaware | 7 | 283−1.8%/yr | −1.8%/yr | 1.6 | 15% | 360 in 2030+4%/yr |
| West Virginia | 2 | 183−11%/yr | −11%/yr | 0.8 | 0% | 160 in 2030−2.2%/yr |
| District of Columbia | 2 | 158−2.2%/yr | −2.2%/yr | 2.5 | 10% | 160 in 2030−0.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Lumbar fusion | 45 | 1,762−4.7%/yr | −4.7%/yr | 3.51.1× | 1% | 1,970 in 2030+1.9%/yr |
| Decompression & minimally invasive spine | 44 | 1,608−8.9%/yr | −8.9%/yr | 3.21.0× | 1% | 1,650 in 2030+0.4%/yr |
| Kyphoplasty & vertebroplasty | 16 | 1,356−6.7%/yr | −6.7%/yr | 2.81.6× | 48% | 1,260 in 2030−1.2%/yr |
| SI joint fusion | 9 | 370+24%/yr | +24%/yr | 0.72.2× | 54% | 610 in 2030+8.7%/yr |
Cervical fusion & disc arthroplasty in every state, and its device makers · Every procedure market in Oklahoma · Every state · Compare with Texas
Aurora Spine leads with 64% of company spending on these surgeons in 2025, +64 pts on 2024.
In 2025, 13 companies reported engagement with Oklahoma’s surgeons worth $79K in consulting, speaking, meals and travel tied to these products, about $2,824 per surgeon billing it. Royalties are left out.
FDA, last 12 months: 69 clearances and approvals in the category, 4 recalled product lines. A recall is a public FDA notice, not a finding of fault.
Which surgeons each company engages, and the dollars reported, are in the ranking. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing. Every company in the category.
Share of the cases CMS names by surgeon, by where they billed. Open one for its ranking.